Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 95 entries
Sorted by: Best Match Show Resources per page
Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 2015;38:264-270.

Diabetes care

Harding JL, Shaw JE, Peeters A, Cartensen B, Magliano DJ.
PMID: 25805866
Diabetes Care. 2015 Apr;38(4):734-5. doi: 10.2337/dc15-er04a.

No abstract available.

Cite
Harding JL, Shaw JE, Peeters A, et al. Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 2015;38:264-270. Diabetes Care. 2015;38(4):734-5doi: 10.2337/dc15-er04a.
Harding, J. L., Shaw, J. E., Peeters, A., Cartensen, B., & Magliano, D. J. (2015). Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 2015;38:264-270. Diabetes care, 38(4), 734-5. https://doi.org/10.2337/dc15-er04a
Harding, Jessica L, et al. "Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 2015;38:264-270." Diabetes care vol. 38,4 (2015): 734-5. doi: https://doi.org/10.2337/dc15-er04a
Harding JL, Shaw JE, Peeters A, Cartensen B, Magliano DJ. Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care 2015;38:264-270. Diabetes Care. 2015 Apr;38(4):734-5. doi: 10.2337/dc15-er04a. PMID: 25805866.
Copy Download .nbib Format: NLM
Lesion of the Cauda Equina: Operation-Relief of Symptoms.

Bristol medico-chirurgical journal (1883)

Shaw JE, Bush JP.
PMID: 28896576
Bristol Med Chir J (1883). 1893 Sep;11(41):161-171.

No abstract available.

Cite
Shaw JE, Bush JP. Lesion of the Cauda Equina: Operation-Relief of Symptoms. Bristol Med Chir J (1883). 1893;11(41):161-171
Shaw, J. E., & Bush, J. P. (1893). Lesion of the Cauda Equina: Operation-Relief of Symptoms. Bristol medico-chirurgical journal (1883), 11(41), 161-171.
Shaw, J E, and Bush, J Paul. "Lesion of the Cauda Equina: Operation-Relief of Symptoms." Bristol medico-chirurgical journal (1883) vol. 11,41 (1893): 161-171.
Shaw JE, Bush JP. Lesion of the Cauda Equina: Operation-Relief of Symptoms. Bristol Med Chir J (1883). 1893 Sep;11(41):161-171. PMID: 28896576; PMCID: PMC5044422.
Copy Download .nbib Format: NLM
Some Points in Lunacy Practice in Relation to the General Practitioner: Abstract of the Presidential Address Delivered on October 13th, 1897, at the Opening of the 24th Session of the Bristol Medico-Chirurgical Society.

Bristol medico-chirurgical journal (1883)

Shaw JE.
PMID: 28897217
Bristol Med Chir J (1883). 1897 Dec;15(58):301-309.

No abstract available.

Cite
Shaw JE. Some Points in Lunacy Practice in Relation to the General Practitioner: Abstract of the Presidential Address Delivered on October 13th, 1897, at the Opening of the 24th Session of the Bristol Medico-Chirurgical Society. Bristol Med Chir J (1883). 1897;15(58):301-309
Shaw, J. E. (1897). Some Points in Lunacy Practice in Relation to the General Practitioner: Abstract of the Presidential Address Delivered on October 13th, 1897, at the Opening of the 24th Session of the Bristol Medico-Chirurgical Society. Bristol medico-chirurgical journal (1883), 15(58), 301-309.
Shaw, J E. "Some Points in Lunacy Practice in Relation to the General Practitioner: Abstract of the Presidential Address Delivered on October 13th, 1897, at the Opening of the 24th Session of the Bristol Medico-Chirurgical Society." Bristol medico-chirurgical journal (1883) vol. 15,58 (1897): 301-309.
Shaw JE. Some Points in Lunacy Practice in Relation to the General Practitioner: Abstract of the Presidential Address Delivered on October 13th, 1897, at the Opening of the 24th Session of the Bristol Medico-Chirurgical Society. Bristol Med Chir J (1883). 1897 Dec;15(58):301-309. PMID: 28897217; PMCID: PMC5050730.
Copy Download .nbib Format: NLM
Walter Holbrook Gaskell.

Clinical cardiology

Silverman ME, Upshaw CB.
PMID: 18636532
Clin Cardiol. 2008 Jul;31(7):340-1. doi: 10.1002/clc.20346.

No abstract available.

Cite
Silverman ME, Upshaw CB. Walter Holbrook Gaskell. Clin Cardiol. 2008;31(7):340-1doi: 10.1002/clc.20346.
Silverman, M. E., & Upshaw, C. B. (2008). Walter Holbrook Gaskell. Clinical cardiology, 31(7), 340-1. https://doi.org/10.1002/clc.20346
Silverman, Mark E, and Upshaw, Charles B. "Walter Holbrook Gaskell." Clinical cardiology vol. 31,7 (2008): 340-1. doi: https://doi.org/10.1002/clc.20346
Silverman ME, Upshaw CB. Walter Holbrook Gaskell. Clin Cardiol. 2008 Jul;31(7):340-1. doi: 10.1002/clc.20346. PMID: 18636532; PMCID: PMC6653270.
Copy Download .nbib Format: NLM
Prediabetes: lifestyle, pharmacotherapy or regulation?.

Therapeutic advances in endocrinology and metabolism

Shaw JE.
PMID: 31321022
Ther Adv Endocrinol Metab. 2019 Jul 10;10:2042018819863020. doi: 10.1177/2042018819863020. eCollection 2019.

The rapidly rising number of people with diabetes worldwide has led to multiple attempts to identify effective means of preventing type 2 diabetes. Lifestyle interventions have shown impressive efficacy in multiple clinical trials of people with impaired glucose tolerance,...

Cite
Shaw JE. Prediabetes: lifestyle, pharmacotherapy or regulation?. Ther Adv Endocrinol Metab. 2019;10:2042018819863020doi: 10.1177/2042018819863020.
Shaw, J. E. (2019). Prediabetes: lifestyle, pharmacotherapy or regulation?. Therapeutic advances in endocrinology and metabolism, 102042018819863020. https://doi.org/10.1177/2042018819863020
Shaw, Jonathan E. "Prediabetes: lifestyle, pharmacotherapy or regulation?." Therapeutic advances in endocrinology and metabolism vol. 10 (2019): 2042018819863020. doi: https://doi.org/10.1177/2042018819863020
Shaw JE. Prediabetes: lifestyle, pharmacotherapy or regulation?. Ther Adv Endocrinol Metab. 2019 Jul 10;10:2042018819863020. doi: 10.1177/2042018819863020. eCollection 2019. PMID: 31321022; PMCID: PMC6624909.
Copy Download .nbib Format: NLM
An Interactive Web Application for the Statistical Analysis of Continuous Glucose Monitoring Data in Epidemiological Studies.

Journal of diabetes science and technology

De Livera AM, Shaw JE, Cohen N, Reutens A, Salim A.
PMID: 33435712
J Diabetes Sci Technol. 2021 Jan 12;1932296820985570. doi: 10.1177/1932296820985570. Epub 2021 Jan 12.

MOTIVATION: Continuous glucose monitoring (CGM) systems are an essential part of novel technology in diabetes management and care. CGM studies have become increasingly popular among researchers, healthcare professionals, and people with diabetes due to the large amount of useful...

Cite
De Livera AM, Shaw JE, Cohen N, et al. An Interactive Web Application for the Statistical Analysis of Continuous Glucose Monitoring Data in Epidemiological Studies. J Diabetes Sci Technol. 2021;1932296820985570doi: 10.1177/1932296820985570.
De Livera, A. M., Shaw, J. E., Cohen, N., Reutens, A., & Salim, A. (2021). An Interactive Web Application for the Statistical Analysis of Continuous Glucose Monitoring Data in Epidemiological Studies. Journal of diabetes science and technology, 1932296820985570. https://doi.org/10.1177/1932296820985570
De Livera, Alysha M, et al. "An Interactive Web Application for the Statistical Analysis of Continuous Glucose Monitoring Data in Epidemiological Studies." Journal of diabetes science and technology vol. (2021): 1932296820985570. doi: https://doi.org/10.1177/1932296820985570
De Livera AM, Shaw JE, Cohen N, Reutens A, Salim A. An Interactive Web Application for the Statistical Analysis of Continuous Glucose Monitoring Data in Epidemiological Studies. J Diabetes Sci Technol. 2021 Jan 12;1932296820985570. doi: 10.1177/1932296820985570. Epub 2021 Jan 12. PMID: 33435712.
Copy Download .nbib Format: NLM
Impact of executive functioning on health-related quality of life of pediatric brain tumor survivors.

Pediatric blood & cancer

Murphy C, Upshaw NC, Thomas AS, Fong G, Janss A, Mazewski C, Ingerski LM.
PMID: 34047487
Pediatr Blood Cancer. 2021 Aug;68(8):e29130. doi: 10.1002/pbc.29130. Epub 2021 May 27.

BACKGROUND: Brain tumor survivors are at risk for significant late effects following treatment completion that may adversely impact health-related quality of life (HRQOL). The current study examines the relationship between executive functioning (EF) and HRQOL in pediatric brain tumor...

Cite
Murphy C, Upshaw NC, Thomas AS, et al. Impact of executive functioning on health-related quality of life of pediatric brain tumor survivors. Pediatr Blood Cancer. 2021;68(8):e29130doi: 10.1002/pbc.29130.
Murphy, C., Upshaw, N. C., Thomas, A. S., Fong, G., Janss, A., Mazewski, C., & Ingerski, L. M. (2021). Impact of executive functioning on health-related quality of life of pediatric brain tumor survivors. Pediatric blood & cancer, 68(8), e29130. https://doi.org/10.1002/pbc.29130
Murphy, Camara, et al. "Impact of executive functioning on health-related quality of life of pediatric brain tumor survivors." Pediatric blood & cancer vol. 68,8 (2021): e29130. doi: https://doi.org/10.1002/pbc.29130
Murphy C, Upshaw NC, Thomas AS, Fong G, Janss A, Mazewski C, Ingerski LM. Impact of executive functioning on health-related quality of life of pediatric brain tumor survivors. Pediatr Blood Cancer. 2021 Aug;68(8):e29130. doi: 10.1002/pbc.29130. Epub 2021 May 27. PMID: 34047487.
Copy Download .nbib Format: NLM
IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.

JNCI cancer spectrum

Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Pollak MN, Nixon AB, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Benson AB, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, Mayer RJ, Blanke CD, Fuchs CS, Meyerhardt JA.
PMID: 33426464
JNCI Cancer Spectr. 2020 Aug 27;5(1):pkaa074. doi: 10.1093/jncics/pkaa074. eCollection 2021 Feb.

BACKGROUND: Energy balance-related biomarkers are associated with risk and prognosis of various malignancies. Their relationship to survival in metastatic colorectal cancer (mCRC) requires further study.METHODS: Baseline plasma insulin-like growth factor (IGF)-1, IGF-binding protein (IGFBP)-3, IGFBP-7, C-peptide, and adiponectin were...

Cite
Guercio BJ, Zhang S, Ou FS, et al. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr. 2020;5(1):pkaa074doi: 10.1093/jncics/pkaa074.
Guercio, B. J., Zhang, S., Ou, F. S., Venook, A. P., Niedzwiecki, D., Lenz, H. J., Innocenti, F., Pollak, M. N., Nixon, A. B., Mullen, B. C., O'Neil, B. H., Shaw, J. E., Polite, B. N., Benson, A. B., Atkins, J. N., Goldberg, R. M., Brown, J. C., O'Reilly, E. M., Mayer, R. J., Blanke, C. D., Fuchs, C. S., & Meyerhardt, J. A. (2021). IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI cancer spectrum, 5(1), pkaa074. https://doi.org/10.1093/jncics/pkaa074
Guercio, Brendan J, et al. "IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405." JNCI cancer spectrum vol. 5,1 (2021): pkaa074. doi: https://doi.org/10.1093/jncics/pkaa074
Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Pollak MN, Nixon AB, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Benson AB, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, Mayer RJ, Blanke CD, Fuchs CS, Meyerhardt JA. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr. 2020 Aug 27;5(1):pkaa074. doi: 10.1093/jncics/pkaa074. eCollection 2021 Feb. PMID: 33426464; PMCID: PMC7785047.
Copy Download .nbib Format: NLM
Response to Comment on Nanditha et al. Secular TRends in DiabEtes in India (STRiDE-I): Change in Prevalence in 10 Years Among Urban and Rural Populations in Tamil Nadu. Diabetes Care 2019;42:476-485.

Diabetes care

Ramachandran A, Snehalatha C, Shaw JE, Susairaj P, Simon M, Vijaya L, Satheesh K, Vinitha R, Raghavan A, Nanditha A.
PMID: 31332034
Diabetes Care. 2019 Aug;42(8):e139-e140. doi: 10.2337/dci19-0027.

No abstract available.

Cite
Ramachandran A, Snehalatha C, Shaw JE, et al. Response to Comment on Nanditha et al. Secular TRends in DiabEtes in India (STRiDE-I): Change in Prevalence in 10 Years Among Urban and Rural Populations in Tamil Nadu. Diabetes Care 2019;42:476-485. Diabetes Care. 2019;42(8):e139-e140doi: 10.2337/dci19-0027.
Ramachandran, A., Snehalatha, C., Shaw, J. E., Susairaj, P., Simon, M., Vijaya, L., Satheesh, K., Vinitha, R., Raghavan, A., & Nanditha, A. (2019). Response to Comment on Nanditha et al. Secular TRends in DiabEtes in India (STRiDE-I): Change in Prevalence in 10 Years Among Urban and Rural Populations in Tamil Nadu. Diabetes Care 2019;42:476-485. Diabetes care, 42(8), e139-e140. https://doi.org/10.2337/dci19-0027
Ramachandran, Ambady, et al. "Response to Comment on Nanditha et al. Secular TRends in DiabEtes in India (STRiDE-I): Change in Prevalence in 10 Years Among Urban and Rural Populations in Tamil Nadu. Diabetes Care 2019;42:476-485." Diabetes care vol. 42,8 (2019): e139-e140. doi: https://doi.org/10.2337/dci19-0027
Ramachandran A, Snehalatha C, Shaw JE, Susairaj P, Simon M, Vijaya L, Satheesh K, Vinitha R, Raghavan A, Nanditha A. Response to Comment on Nanditha et al. Secular TRends in DiabEtes in India (STRiDE-I): Change in Prevalence in 10 Years Among Urban and Rural Populations in Tamil Nadu. Diabetes Care 2019;42:476-485. Diabetes Care. 2019 Aug;42(8):e139-e140. doi: 10.2337/dci19-0027. PMID: 31332034.
Copy Download .nbib Format: NLM
Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma.

Cancers

Anand K, Roszik J, Gombos D, Upshaw J, Sarli V, Meas S, Lucci A, Hall C, Patel S.
PMID: 31226786
Cancers (Basel). 2019 Jun 20;11(6). doi: 10.3390/cancers11060856.

Nearly 50% of uveal melanoma (UM) patients develop metastatic disease, and there remains no current standard assay for detection of minimal residual disease. We conducted a pilot study to check the feasibility of circulating tumor cell (CTC) detection in...

Cite
Anand K, Roszik J, Gombos D, et al. Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma. Cancers (Basel). 2019;11(6)doi: 10.3390/cancers11060856.
Anand, K., Roszik, J., Gombos, D., Upshaw, J., Sarli, V., Meas, S., Lucci, A., Hall, C., & Patel, S. (2019). Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma. Cancers, 11(6), . https://doi.org/10.3390/cancers11060856
Anand, Kartik, et al. "Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma." Cancers vol. 11,6 (2019). doi: https://doi.org/10.3390/cancers11060856
Anand K, Roszik J, Gombos D, Upshaw J, Sarli V, Meas S, Lucci A, Hall C, Patel S. Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma. Cancers (Basel). 2019 Jun 20;11(6). doi: 10.3390/cancers11060856. PMID: 31226786; PMCID: PMC6628316.
Copy Download .nbib Format: NLM
The Future Burden of Head and Neck Cancers Attributable to Modifiable Behaviors in Australia: A Pooled Cohort Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Laaksonen MA, Canfell K, MacInnis RJ, Banks E, Byles JE, Giles GG, Magliano DJ, Shaw JE, Hirani V, Gill TK, Mitchell P, Cumming RG, Salagame U, Vajdic CM.
PMID: 34020998
Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1566-1574. doi: 10.1158/1055-9965.EPI-21-0003. Epub 2021 May 21.

BACKGROUND: Estimates of future burden of cancer attributable to current modifiable causal exposures can guide cancer prevention. We quantified future head and neck cancer burden in Australia attributable to individual and joint causal exposures, and assessed whether these burdens...

Cite
Laaksonen MA, Canfell K, MacInnis RJ, et al. The Future Burden of Head and Neck Cancers Attributable to Modifiable Behaviors in Australia: A Pooled Cohort Study. Cancer Epidemiol Biomarkers Prev. 2021;30(8):1566-1574doi: 10.1158/1055-9965.EPI-21-0003.
Laaksonen, M. A., Canfell, K., MacInnis, R. J., Banks, E., Byles, J. E., Giles, G. G., Magliano, D. J., Shaw, J. E., Hirani, V., Gill, T. K., Mitchell, P., Cumming, R. G., Salagame, U., & Vajdic, C. M. (2021). The Future Burden of Head and Neck Cancers Attributable to Modifiable Behaviors in Australia: A Pooled Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 30(8), 1566-1574. https://doi.org/10.1158/1055-9965.EPI-21-0003
Laaksonen, Maarit A, et al. "The Future Burden of Head and Neck Cancers Attributable to Modifiable Behaviors in Australia: A Pooled Cohort Study." Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology vol. 30,8 (2021): 1566-1574. doi: https://doi.org/10.1158/1055-9965.EPI-21-0003
Laaksonen MA, Canfell K, MacInnis RJ, Banks E, Byles JE, Giles GG, Magliano DJ, Shaw JE, Hirani V, Gill TK, Mitchell P, Cumming RG, Salagame U, Vajdic CM. The Future Burden of Head and Neck Cancers Attributable to Modifiable Behaviors in Australia: A Pooled Cohort Study. Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1566-1574. doi: 10.1158/1055-9965.EPI-21-0003. Epub 2021 May 21. PMID: 34020998.
Copy Download .nbib Format: NLM
In-hospital mortality, length of stay and hospital costs for hospitalized breast cancer patients with comorbid heart failure in the USA.

Current medical research and opinion

Park C, Park SK, Upshaw JN, Schonberg MA.
PMID: 34525896
Curr Med Res Opin. 2021 Dec;37(12):2043-2047. doi: 10.1080/03007995.2021.1980775. Epub 2021 Sep 29.

OBJECTIVES: Breast cancer and heart failure (HF) are frequently interconnected due to shared risk factors and the cardiotoxicity of breast cancer treatment. However, the association between HF and hospital outcomes among breast cancer patients has not been studied. This...

Cite
Park C, Park SK, Upshaw JN, et al. In-hospital mortality, length of stay and hospital costs for hospitalized breast cancer patients with comorbid heart failure in the USA. Curr Med Res Opin. 2021;37(12):2043-2047doi: 10.1080/03007995.2021.1980775.
Park, C., Park, S. K., Upshaw, J. N., & Schonberg, M. A. (2021). In-hospital mortality, length of stay and hospital costs for hospitalized breast cancer patients with comorbid heart failure in the USA. Current medical research and opinion, 37(12), 2043-2047. https://doi.org/10.1080/03007995.2021.1980775
Park, Chanhyun, et al. "In-hospital mortality, length of stay and hospital costs for hospitalized breast cancer patients with comorbid heart failure in the USA." Current medical research and opinion vol. 37,12 (2021): 2043-2047. doi: https://doi.org/10.1080/03007995.2021.1980775
Park C, Park SK, Upshaw JN, Schonberg MA. In-hospital mortality, length of stay and hospital costs for hospitalized breast cancer patients with comorbid heart failure in the USA. Curr Med Res Opin. 2021 Dec;37(12):2043-2047. doi: 10.1080/03007995.2021.1980775. Epub 2021 Sep 29. PMID: 34525896.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 95 entries